Tempus founder and CEO Eric Lefkofsky joins ‘The Claman Countdown’ to discuss how artificial intelligence is transforming precision medicine.
Precision medicine is entering a new era as artificial intelligence helps identify hidden cancer patterns. Tempus founder and CEO Eric Lefkofsky explains to Liz Claman how the company builds advanced oncology foundation models. By analyzing hundreds of petabytes of clinical data, these powerful AI systems find invisible trends to customize therapies, deliver correct dosages, and lower patient mortality rates.
Read the full article here